INTRODUCTION
Serum aminotransferases, such as AST and ALT, are considered the representative markers for hepatocellular necrosis in acute or chronic hepatitis. When hepatotoxic events occur, the damage to hepatocytes and the increased permeability of hepatocyte cell membrane may contribute to the intra-vascular spread of these enzymes from hepatocytes, which reflects the current hepatic inflammation. On the other hand, aminotransferase is also present in the skeletal muscle, heart, kidney, brain, and erythrocytes. Hence, the elevated serum aminotransferase level may originate from an extrahepatic organ. 1 Rhabdomyolysis is a well-known condition, in which a high serum aminotransferase level is not a marker for hepatocellular necrosis. Several studies reported that the change in serum AST and ALT is correlated with the serum creatinine kinase (CK) level, which suggests that elevated aminotransferase in rhabdomyolysis might be a marker for a skeletal muscle injury instead of hepatocyte damage. [2] [3] [4] On the other hand, there is limited data on the serum aminotransferase level in rhabdomyolysis in cases of coexistent liver disease. Therefore, this study evaluated the serum aminotransferase level in rhabdomyolysis to determine if concurrent liver disease is present. In addition, the aminotransferase level in rhabdomyolysis and alcoholic liver disease without rhabdomyolysis was compared.
SUBJECTS AND METHODS

Study subjects
Rhabdomyolysis was defined as a serum CK level above N17.9, rhabdomyolysis related to acute renal failure; T79.6, traumatic rhabdomyolysis) on an electronic medical record review. Among them, 165 patients were selected after excluding those in whom the serum CK was <1,000 U/L or unavailable, and those who had other causes of the elevated CK levels, such as acute myocardial infarction, brain hemorrhage, or mul-ti-organ dysfunction ( Fig. 1 ).
To compare with other diseases with a similar pattern of aminotransferase elevation, 146 patients with the alcoholic liver disease without rhabdomyolysis were selected from those admitted in the same hospital from April 1, 2010 and February 28, 2011. The Institutional Review Board of Inje University Haeundae Paik Hospital approved this study (No. 129792-2013-106). Informed consent was waived because this study was based on a retrospective medical record review.
Data collection
The following demographic and laboratory data were collected: the cause of rhabdomyolysis, age, gender, CK, complete blood count, INR, total bilirubin, GGT, LDH, BUN, creatinine, CRP, AST, ALT, and concurrent liver disease at admission and hemodialysis during admission. In addition, the peak level of CK (upper measurement limit, 10,000 U/L), AST, ALT, INR, LDH, BUN, and creatinine during admission were collected.
Statistical analysis
Descriptive statistics of the baseline and peak levels of the laboratory findings were obtained from the patients with rhabdomyolysis. The clinical data, including CK, AST, ALT, and AST/ALT ratio at the peak AST time, were compared according to the presence of concurrent liver disease. The same clinical data between the patients with rhabdomyolysis and those with the alcoholic liver disease without rhabdomyolysis were also compared. The categorical variables were assessed using a chi-square test or Fisher's exact test. Continuous variables were assessed by Student's t-test. A p-value <0.05 was considered significant. Statistical analyses were performed using SPSS, version 25.0 (SPSS Inc., Chicago, IL, USA) and R (version 3.5.3; available from: http://cran.r-project.org/). of reasons, seizure, sepsis, etc. (Table 1 and Fig. 2 ).
RESULTS
Cause of rhabdomyolysis
Baseline characteristics of the patients with rhabdomyolysis
The mean age of the patients was 51.8 years, and the male gender was predominant (63.6%). The initial CK level was 4,032 U/L, and mild leukocytosis and CRP elevation were observed. The initial AST and ALT levels were 121 and 52 U/L, respectively. Among them, 19 patients had concurrent liver disease; HBV in four, HCV in one, alcohol in 13, and drug-induced liver injury (culprit drug: simvastatin) in one (Table 2) .
Peak laboratory findings during admission
During admission, the peak CK level and peak LDH level Hemodialysis 11 (6.7)
The upper limit of measurement of creatinine kinase was 10,000 U/L. INR, international normalization ratio; AST, aspartate aminotransferase; ALT, alanine aminotransferase; BUN, blood urea nitrogen. a This value is a median (range); b This value is a median (interquartile range). Fig. 3 . Distribution of serum AST and ALT in the patients with rhabdomyolysis according to the presence of liver disease. Seven and two outliers of serum AST over 2,000 U/L in the patients with or without liver disease were omitted, respectively. Two outliers of serum ALT over 2,000 U/L in those without liver disease were omitted in this graph. The mean and median value of each variable was described as a red triangle and black thick horizontal bar in the box respectively. AST, aspartate aminotransferase; ALT, alanine aminotransferase.
upper limit of normal (38 U/L) was 97.8%, and that of the peak ALT over the upper limit of normal (43 U/L) was 84.1% ( Fig. 3 and Table 3 ). all the values were similar in both groups (Table 4 ).
Clinical and laboratory findings in patients with rhabdomyolysis and alcoholic liver disease without rhabdomyolysis
Compared to the patients who were admitted due to alco- 
DISCUSSION
This study showed that the serum aminotransferase level was not significantly different in patients with rhabdomyolysis regardless of concurrent liver disease. In addition, the peak AST level was higher in those with rhabdomyolysis than in alcoholic liver disease, but the AST/ALT ratio could not distinguish the two diseases effectively. Rhabdomyolysis is one of the representative conditions, in which serum aminotransferase is elevated without significant liver disease, and AST is usually higher than ALT. According to another study, the serum peak AST level was correlated with the peak CK, and the serial test result during admission showed a similar pattern between both enzymes. 2, 4 These findings suggest that an elevated AST level in rhabdomyolysis might be a marker of skeletal muscle injury instead of hepatocyte damage. In the present study, serum peak AST elevation was approximately five times the upper limit of normal, and the peak ALT elevation was more than two times the upper limit of normal, which concurs with a previous study. 4 An elevated AST level is intuitively explainable because AST is one of the sarcoplasmic proteins. On the other hand, ALT is usually accepted as a more specific marker for hepatocyte injury. Nevertheless, a study reported that there is evidence of ALT production outside of the liver. For example, the skeletal muscle, heart, and kidneys contained 10%, 15%, and 40% of the ALT concentration found in the liver, respectively. 5 Therefore, ALT elevation is also possible in the case of a skeletal muscle injury without liver damage.
Initially, this study examined whether the serum aminotransferase level is higher in the group with rhabdomyolysis and concurrent liver disease than in those with only rhabdomyolysis. In the present study, the AST and ALT levels were similar in the two groups, but the AST level was slightly The AST/ALT ratio is helpful for differentiating the kind of acute or chronic liver disease. In acute viral hepatitis, the AST/ALT ratio is generally less than one. In contrast, the AST/ALT ratio is usually more than one in alcoholic hepatitis or cirrhosis. In particular, alcoholic hepatitis presents with AST/ALT ratios >2-3. 6, 7 Therefore, this study compared the aminotransferase and AST/ALT ratio in those with rhabdomyolysis and those with the alcoholic liver disease without muscle injury. The AST and ALT levels were higher in the rhabdomyolysis group, but without statistical significance. The AST/ALT ratio was approximately 2.5 in both groups. Hence, it might not be helpful for discriminating between the two groups.
This study has some limitations. First, in the case of sepsis, some patients might experience hypotension, which could in-duce an ischemic hepatic injury. Thus, it is impossible to discriminate the cause of the elevated aminotransferase between rhabdomyolysis and ischemic hepatic injury precisely.
To minimize the controversial cases, multi-organ failure, which might be associated with septic shock, was excluded. Second, this was a type of cross-sectional study to describe an episode of rhabdomyolysis. Therefore, it is difficult to present the causality or relationship between the elevated aminotransferase and rhabdomyolysis directly. Most patients had an initial routine viral hepatitis serology but an examination of the rare causes of acute or chronic hepatitis was not performed.
Nevertheless, the physicians tried to refer to hepatology in suspicious cases of chronic liver disease after discharge. In addition, except one index case of chronic viral hepatitis, no one showed an aggravation of the liver function. Third, the alcoholic liver disease group did not include the pure aggravated liver function case due to alcohol intake exclusively.
Owing to the high proportion of cirrhosis cases, some patients were admitted due to variceal bleeding, encephalopathy, and systemic infection. Thus, this cohort might not present with a higher AST/ALT ratio as expected in pure alcoholic hepatitis.
Finally, the number of patients with rhabdomyolysis and concurrent liver disease was too small, which may have affected the statistical reliability to compare the variables between the rhabdomyolysis alone group and rhabdomyolysis with liver disease group.
In conclusion, patients with rhabdomyolysis showed elevated aminotransferase levels, both AST and ALT. The degree of the elevation was similar in the patients with and without concurrent liver disease. The AST/ALT ratio in rhabdomyolysis increased in a similar manner to those with alcoholic liver disease. Therefore, it is important to consider rhabdomyolysis in a differential diagnosis in cases of an elevated AST-dominant aminotransferase level in patients with a suspicious skeletal muscle injury.
